Effect of obesity, glucose control, lipid profiles, and blood pressure on Lp-PLA2 levels in type 2 diabetes mellitus patients
Authors:
- Liong Boy KurniawanLKLiong Boy Kurniawan
- Herniaty RampoHRHerniaty Rampo
- Gita Vita SorayaGSGita Vita Soraya
- Endy AdnanEAEndy Adnan
- Tenri EsaTETenri Esa
- Yuyun WidaningsihYWYuyun Widaningsih
- Uleng BahrunUBUleng Bahrun
- Mansyur ArifMAMansyur Arif
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Obesity Medicine
- Vol. 22
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Association of body composition indexes with cardio-metabolic risk factorsObesity Medicine, 2020
- Lp-PLA2 activity and mass and CRP are associated with incident symptomatic peripheral arterial diseaseScientific Reports, 2019
- Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of StatinsJournal of Neurosciences in Rural Practice, 2018
- Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitusIndian Journal of Medical Research, 2015
- Lipoprotein-Associated Phospholipase A2Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes MellitusJournal of Diabetes Research, 2014
- Lipoprotein-Associated Phospholipase A2Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary SyndromeYonsei Medical Journal, 2014
- Body Fat Distribution and Risk of Cardiovascular DiseaseCirculation, 2012
- Phospholipase A2 structure/function, mechanism, and signalingJournal of Lipid Research, 2009
- Lipoprotein-Associated Phospholipase A2 Is an Independent Predictor of Incident Coronary Heart Disease in an Apparently Healthy Older PopulationJACC, 2008
- Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic riskEuropean Heart Journal Supplements, 2006